Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services... see more

NDAQ:VMD - Post Discussion

Viemed Healthcare Inc > 8.7% increase to vent reimbursement rates for 2023
View:
Post by lscfa on Dec 01, 2022 5:17pm

8.7% increase to vent reimbursement rates for 2023

CMS UPDATES DMEPOS PAYMENTS 

WASHINGTON – CMS today announced a 9.1% increase for competitively bid DMEPOS items in non-competitive bidding areas and a 6.4% increase for bid items in former CBAs for calendar year 2023, AAHomecare reports. 

Non-bid items will receive an 8.7% increase. 

Typically, the CPI-U increases for DME have been 1%-3%. Last year, the inflation adjustment was 5% in former CBAs and 5.4% non-CBAs. 

“These increases will help DME suppliers who have been dealing with rising product and operational costs over that last two years, but more comprehensive adjustments are needed,” said Tom Ryan, AAHomecare president and CEO. “Thanks to the cancellation of one bidding round and the decision not to implement results of the most recent round, DME rates remain disconnected to the market realities suppliers face. That has to change, and it has to change now.” 

CMS will be publishing the official CY 2023 fee schedule soon. 

See the Calendar Year 2023 Update for DMEPOS Fee Schedule (CMS Claims Processing Update Change Request 13006) for more information.

Comment by LongTerm3 on Dec 01, 2022 5:39pm
This is great for Viemed, an they continue to grow patient count.
Comment by Carlito3211 on Dec 01, 2022 6:13pm
Besttobe isnt going to be happy about this. lol.
Comment by LongTerm3 on Dec 01, 2022 6:16pm
I think he works at FTX. Compliance!
Comment by lscfa on Dec 01, 2022 6:44pm
9127 vent patients x $10,000 net rev/yr x 8.70% increase = $8 mil US revenue increase pre-tax, $5.6 mil after-tax.   $5.56 mil /  40 mil shares = $0.14/sh x 15 multiple = $2.10 US increase in share value.
Comment by LongTerm3 on Dec 01, 2022 8:04pm
Question - do all 9,127 patients fall under the 8.7 percent increase? Patient count is moving up the last 6 months, and should continue to grow as per conference call so the numbers should be very good. The last four months they barely hired any people so there overhead should be fine.
Comment by besttobe on Dec 06, 2022 3:48pm
Appears the market doesn't think much of the CMS cpi hike. I am sure their employees will be happy about it though, as they seek wage increases.  We shall see.....
Comment by LongTerm3 on Dec 06, 2022 4:06pm
Why would the stock be up, when the market is getting killed? LOL
Comment by Carlito3211 on Dec 06, 2022 4:14pm
Besttobe thinks we are so stupid that we will think the same thing is happening to VMD which is happening to a utility company he bought a month ago and is down several bucks a share on. Up to his eyeballs in losses. lol.
Comment by lscfa on Dec 06, 2022 4:13pm
The market will wake up when the inflation-adjusted reimbursement increase hits the bottom line of Q1 fins.    
Comment by besttobe on Dec 06, 2022 4:40pm
Isfca "The market will wake up when the inflation-adjusted reimbursement increase hits the bottom line of Q1 fins. " Reminds of the time MGT said SG&A expenses would be flat.fixed and profits would go to straight to the bottom line and you bought into it. Not going to happen.... Show me..
Comment by lscfa on Dec 20, 2022 2:27pm
 market waking up?
Comment by lscfa on Dec 20, 2022 2:29pm
recall this post.....
Comment by LongTerm3 on Dec 20, 2022 2:49pm
I don't think the increase plays into the move up today.  Fundamentally the stock is just to cheap with what it has going on with the company.
Comment by yureja85 on Dec 02, 2022 1:49am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities